Orenitramhcp.com

Orenitramhcp.com has Server used 45.60.106.59 IP Address with Hostname in United States. Below listing website ranking, Similar Webs, Backlinks. This domain was first 2020-09-30 (1 year, 272 days) and hosted in Dover United States, server ping response time 6 ms

DNS & Emails Contact

This tool is used to extract the DNS and Emails from this domain uses to contact the customer.

Fetching Emails ...

Extract All Emails from Domain

Top Keywords Suggestions

Keywords suggestion tool used Orenitramhcp keyword to suggest some keywords related from this domain. If you want more, you can press button Load more »

1 Orenitram hcp

Hosting Provider

Website: Orenitramhcp.com
Hostname: 45.60.106.59
Country:
NetName:
Address: 3400 Bridge Parkway, Suite 200,
Region: DE
City: Dover
Postal Code: 19901
Latitude: 39.158798217773
Longitude: -75.494102478027
Area Code: 302
Email Abuse1. [email protected]
2. [email protected]
3. [email protected]
4. [email protected]
5. [email protected]
6. [email protected]
7. [email protected]
8. [email protected]
9. [email protected]
10. [email protected]
11. [email protected]

Find Other Domains on Any IP/ Domain


New! Domain Extensions Updated .com .org .de .net .uk   » more ...

Domains Actived Recently

   » Revo.com (17 hours ago)

   » Bobbyjonesband.com (1 day ago)

   » 1stchoiceautosllc.com (12 hours ago)

   » Huishoubao.com (12 hours ago)

   » M1file.com (15 hours ago)

   » Renhomesantalya.com (6 day ago)

   » Napadrivertours.com (4 day ago)

Results For Websites Listing

Found 8 Websites with content related to this domain, It is result after search with search engine

Orenitramhcp.com   DA: 20 PA: 20 MOZ Rank: 40

  • Imp act Earlier with orenitram1,2
  • Data from the FREEDOM-EV trial show that treatment with Orenitram can delay disease progression AND improve key prognostic measures of risk1-3*
  • Key prognostic measures of risk assessed as secondary endpoints included 6MWD, NT-proBNP, and WHO FC.

Orenciahcp.com   DA: 18 PA: 18 MOZ Rank: 37

  • Important Safety Information for ORENCIA ® (abatacept)
  • Increased Risk of Infection with Concomitant Use with TNF Antagonists, Other Biologic RA/PsA Therapy, or JAK Inhibitors: Concurrent therapy with ORENCIA and a TNF antagonist is not recommended
  • In controlled clinical trials, adult RA patients receiving concomitant intravenous ORENCIA and TNF …

Unitedbyph.com   DA: 18 PA: 22 MOZ Rank: 42

  • Orenitram HCP Video: Measuring Risk and the Impact of Orenitram
  • Jean Elwing, MD, on the effect that Orenitram had on several key parameters of risk, as well as overall risk status in the FREEDOM-EV trial
  • Orenitram HCP Video: Dosing and AE Management as a Team.

Fresno.ucsf.edu   DA: 19 PA: 50 MOZ Rank: 72

  • and Patient Information for Orenitram at www.orenitramhcp.com
  • *Monotherapy may be appropriate for a specific subset of patients in whom the efficacy/safety ratio of initial combination therapy is not established.7 †Patients can be considered for referral for lung transplantation.7 ‡Escalation is dependent on the initial background treatment.7

Unither.com   DA: 15 PA: 16 MOZ Rank: 35

  • The websites of United Therapeutics Corporation and its subsidiaries (collectively, the Company) include "forward-looking statements" within the meaning of the safe harbor provisions of the U.S
  • Private Securities Litigation Reform Act of 1995.These statements include discussions of our pipeline of products, including anticipated research and development efforts and regulatory …

Ajmc.com   DA: 12 PA: 50 MOZ Rank: 67

  • Pulmonary arterial hypertension (PAH) is a severe disease with poor prognosis and shortened life expectancy
  • Treatment has traditionally involved the sequential use of endothelin receptor agonists

Ir.unither.com   DA: 14 PA: 26 MOZ Rank: 46

  • January 2021 Corporate Presentation

Ir.unither.com   DA: 14 PA: 26 MOZ Rank: 47

  • The websites of United Therapeutics Corporation and its subsidiaries (collectively, the Company) include “forward-looking statements” within the meaning of the safe harbor provisions of the U.S
  • Private Securities Litigation Reform Act of 1995.These statements include discussions of our pipeline of products, including anticipated research and …

Recently Analyzed Sites

Revo.com (17 hours ago)

Bobbyjonesband.com (1 day ago)

1stchoiceautosllc.com (12 hours ago)

Huishoubao.com (12 hours ago)

M1file.com (15 hours ago)

Trekksoft.com (12 hours ago)

Tibbo.com (13 day ago)

Nolanavyweek.com (15 seconds ago)

Tailspinbandsc.com (8 day ago)

Dungscanada.com (12 hours ago)

Jfsorange.org (17 hours ago)

Marloweslu.com (4 day ago)